1
Indications & Patient Selection
Classic Presentation
- Nocturnal pain relieved by aspirin or NSAIDs — highly characteristic; driven by elevated prostaglandins (PGE2/PGI2) in the nidus
- Age 5–30 years; male predominance (~4:1 male-to-female ratio)
- Locations: long bones (femur/tibia ~50%), spine (posterior elements), small bones of hands and feet; ischium, patella, skull are atypical
- Painful scoliosis in adolescents — consider spinal OO
Imaging Workup
- CT (thin-slice, ≤1 mm): lucent nidus (<2 cm) surrounded by dense reactive cortical sclerosis — "halo sign"; central mineralized focus may be present
- Bone scan (Tc-99m MDP): near 100% sensitivity; "double density" sign with focal uptake in nidus + surrounding halo
- MRI: less sensitive for nidus but demonstrates perilesional marrow edema (STIR hyperintensity) and joint effusion; useful for spinal lesions
- Radiographs: may be normal or show only reactive thickening; not reliable for nidus identification
Indications for Ablation
- Failed conservative therapy (NSAIDs) ≥6 months — up to 75% respond to NSAIDs alone; ablation reserved for those who do not
- Intolerable pain significantly impairing daily activity or sleep
- Spinal lesions with neurologic risk or scoliosis progression
- Patient preference for definitive treatment over long-term NSAID use
Contraindications
- Nidus >2 cm — consider osteoblastoma or other diagnosis; surgical consultation preferred
- Proximity to bowel or major neurovascular structures without thermal protection strategy
- Pregnancy
- Active infection at access site or suspected osteomyelitis
- Uncorrectable coagulopathy
- Articular cartilage within ablation zone (relative; consider cryo)
2
Pre-Procedure Checklist
NPO 6 hours. General anesthesia is strongly preferred — periosteal drilling is extremely painful and patient movement during probe placement risks displacement. Coordinate with anesthesia team; for pediatric patients, involve pediatric anesthesia.
Review thin-slice CT (≤1 mm slices). Confirm nidus location, size, and depth. Identify reactive sclerosis — the true nidus is the central lucency, not the surrounding sclerosis. Plan percutaneous access trajectory.
Guidance modality. CT is preferred for precise nidus targeting. Fluoroscopy alone is generally inadequate for nidus identification. Consider CT-fluoroscopy for real-time needle guidance.
Equipment. Bone access needle: Bonopty® or Ostycut® 11G coaxial system (or equivalent 13G Osteo-Site®). RFA probe: single-tine or cooled-tip (Cool-tip® Medtronic); 1-cm active tip standard for nidus ≤1 cm; 2-cm tip for larger lesions. Confirm diamond-tip drill availability for sclerotic bone.
Local anesthesia. Generous lidocaine infiltration from skin to periosteum — periosteum is highly innervated and extremely sensitive. Do not underestimate the amount needed even under GA.
Labs. CBC, CMP, INR. Bone procedures are SIR Category 2 (moderate bleeding risk) — correct INR to <1.5 and platelets >50K before proceeding.
Antibiotic prophylaxis. Cefazolin 1g IV (weight-based dosing in pediatric patients) at induction. Bone procedures carry infection risk; prophylaxis is standard practice.
Spinal lesions. If near neural structures: arrange temperature monitoring probe or plan thermal protection (D5W epidural cooling or CO2 pneumodissection). Confirm probe tip will be ≥1 cm from spinal canal on planning CT.
Bone scan (optional but useful). Helpful if nidus is not clearly identifiable on CT alone. Correlate bone scan uptake with CT for lesion localization. Nuclear medicine probe guidance available at some centers.
Consent. Discuss: pain flare (expected, 1–3 days), skin burn risk (subperiosteal lesions), infection/osteomyelitis (<1%), incomplete ablation/recurrence (~5–10%), neurologic risk (spinal, <1% with protection), pathologic fracture (if cortex >50% involved — weightbearing restriction).
3
Relevant Anatomy
Nidus Structure
- Inner nidus: central vascularized fibrous stroma containing osteoid trabeculae with osteoblasts — highly metabolically active; contains prostaglandins 100–1000× normal bone levels
- Outer reactive zone: thickened woven and lamellar bone — the dense sclerotic rim seen on CT; this is NOT the target
- Size: nidus characteristically <2 cm (usually 5–15 mm); lesions >2 cm raise concern for osteoblastoma
- Nidus on CT: rounded or ovoid lucency ± dense central mineralized focus; high T2/STIR signal on MRI with surrounding edema
Location-Specific Anatomy
- Cortical (intracortical): most common; within bony cortex of diaphysis or meta-diaphysis — dense surrounding sclerosis makes drilling challenging
- Cancellous: medullary location; easier needle passage but nidus may be less conspicuous
- Subperiosteal: beneath periosteum, no cortex to drill; highest risk of skin burn from superficial location
- Intra-articular: near articular cartilage — risk of chondral thermal injury; cryo preferred
- Spinal: posterior elements (pedicle, lamina, facet joint); proximity to spinal canal and nerve roots is the key hazard
Proximity Hazards by Location
- Proximal femur: femoral vessels and nerve; periarticular lesions risk femoral head avascular necrosis
- Spine: spinal cord, nerve roots, dural sac; epidural vessels
- Intra-articular (hip, knee, ankle): articular cartilage — limit thermal spread
- Hand/foot small bones: digital nerves and tendons in close proximity
Periosteum
- Highly innervated — primary source of pain during needle placement and drilling
- Generous local anesthesia required from skin to periosteum regardless of general anesthesia
- Subperiosteal lesions: periosteum elevation can spread ablation heat superficially → skin burn risk → hydrodissection with saline or D5W recommended
4
Technique
Default RadCall approach · share your own below
Supplies
CT guidance (preferred)
Bonopty® or Ostycut® 11G coaxial bone needle
RFA probe (1-cm active tip — cooled or single-tine)
Diamond-tip drill bit (for dense sclerosis)
1% lidocaine — generous amount
Cefazolin 1g IV
ChloraPrep / sterile drape
Hemostatic plug (optional)
D5W or saline for hydrodissection
Temperature monitoring probe (spinal lesions)
Sterile dressing
CT-Guided RFA — Standard Protocol
Steps
1
Position and CT planning scan
Position patient prone or supine depending on nidus location. Obtain high-resolution CT planning scan (0.6–1 mm slices) to confirm nidus center. Place localizing grid on skin for entry point planning. Identify the true lucent nidus — do not mistake surrounding reactive sclerosis for the target.
▶ CT — nidus identification pre-ablation
CT planning: classic nidus — lucent center <2 cm with surrounding dense cortical sclerosis; confirm nidus location relative to neurovascular structures before probe placement.
2
Skin prep and local anesthesia
ChloraPrep prep and sterile drape. Mark skin entry site. Infiltrate generous lidocaine from skin to periosteum — periosteum is the most pain-sensitive structure. Even under GA, adequate local infiltration reduces intraoperative hemodynamic responses (expect transient hypertension/tachycardia from prostaglandin release during ablation).
3
Advance bone access needle to nidus
Under CT fluoroscopic guidance, advance the Bonopty®/Ostycut® trocar needle through soft tissue to the periosteum. Confirm position on CT. Advance through reactive cortical sclerosis toward the nidus center — this requires firm pressure and often a twisting motion. If sclerosis is too dense, use the diamond-tip drill bit. Confirm needle tip within the central lucency on CT (within 1 mm of nidus center).
4
Coaxial access and biopsy (optional)
Remove inner stylet. If concurrent biopsy is desired (recommended for histologic confirmation), obtain biopsy sample via the trocar. Then advance the coaxial 11G needle through the trocar to create channel for the RFA probe. Remove the 11G needle while leaving the trocar in place.
5
Insert RFA probe
Insert RFA probe (1-cm active tip) through the trocar coaxially. Advance until the active tip is centered within the nidus. Confirm probe position on CT — active tip should span the nidus. For nidus >8 mm: use a 2-cm active tip or plan two overlapping ablation cycles.
▶ RFA probe tip in osteoid osteoma nidus
Probe tip confirmed in nidus center by CT — verify position before initiating ablation; probe tip must be within nidus for complete thermal kill.
6
Ablation
Perform RFA: heat to 90–95°C for 4–6 minutes (standard protocol). For bipolar probes (Cool-tip®): grounding pads unnecessary; follow manufacturer settings. Expect patient hemodynamic response (transient hypertension/tachycardia) at ablation onset due to prostaglandin release — warn anesthesia team. Repeat cycle if nidus >8 mm or if first cycle target temperature was not achieved. For spinal lesions near neural structures: monitor temperature probe; maintain <45°C at neural elements.
7
Probe removal and hemostasis
Allow probe to cool per manufacturer protocol before removal. Remove probe and coaxial trocar. Apply hemostatic plug at tract if desired. Apply sterile dressing.
8
Post-procedure CT
Obtain immediate post-procedure CT to confirm probe position, assess the ablation zone (gas foci in bone = expected), and exclude complications (hematoma, pneumothorax for rib/thoracic lesions, cortical fracture).
9
Recovery and discharge
Monitor in recovery 1–2 hours. Discharge same day in most cases (pediatric patients at some institutions are admitted overnight). Discharge with NSAIDs ± short acetaminophen course for expected post-procedure pain flare. Non-weight-bearing 4–6 weeks if >50% cortex involved (fracture risk).
Ablation Modality Comparison
| Modality | Mechanism | Advantages | Considerations |
|---|---|---|---|
| RFA (standard) | Alternating current → ionic oscillation → heat | Most evidence base; predictable 90–95°C zone; cooled probes reduce charring | Cannot use near implanted metal; limited by carbonization at high temps |
| Microwave (MWA) | 2.45 GHz EM field → water molecule oscillation → heat | Higher temperatures more rapidly; less affected by heat sink; promising early data | Less literature for OO specifically; requires shorter ablation cycles (30W × 3 min) |
| Cryoablation | Pressurized gas expansion → lethal freezing | Preferred near articular cartilage and neural structures; visible iceball on CT | Requires larger access needle; ice ball less predictable in cortical bone; limited OO-specific series |
| LITT (Laser) | Laser energy → photothermal tissue destruction | MRI-compatible; very precise small zone; useful in difficult locations | Requires MRI guidance suite; less commonly available; less OO-specific data |
Note — Drilling Through Sclerotic Bone: Dense reactive sclerosis surrounding the nidus frequently resists standard needle advancement. Options: (1) diamond-tip drill bit attachment for the coaxial system, (2) manual bone drill with controlled force, (3) high-speed power drill. Avoid excessive torque that can deflect the needle away from the nidus. Concurrent drill biopsy of the nidus for histology is recommended when the lesion is being drilled.
Sign in to view and create community cards
5
Fluoroscopy / CT Landmarks
Key CT Findings
- "Halo sign": dense reactive sclerosis surrounding the central lucent nidus — the sclerosis is the conspicuous finding; the nidus is within it
- Nidus: rounded or ovoid lucency; may contain a dense central calcified focus (mineralized osteoid). Average diameter 5–15 mm
- Central mineralized focus within the lucency should not be confused with the reactive sclerosis — the probe tip targets the lucent nidus around it
- MRI correlation: STIR hyperintensity extending beyond nidus indicates perilesional edema — confirms active lesion
Probe Positioning Targets
- Probe tip within 1 mm of nidus center — required for adequate ablation; minor displacement significantly reduces efficacy
- Active tip length must match nidus size: 1-cm tip for nidus ≤1 cm; 2-cm tip for larger nidus; overlap two 1-cm burns for nidus >1 cm if 2-cm probe unavailable
- Spinal lesions: confirm probe tip is ≥1 cm from posterior spinal canal on axial CT; ≥5 mm from nerve root foramina
- Articular lesions: confirm distance from articular cartilage surface; <1 cm warrants reduced power or cryoablation
- Post-ablation CT: gas foci within the nidus confirm adequate heating; lack of gas may indicate incomplete ablation
6
Troubleshooting
Problem
Sclerotic bone prevents needle or drill advance
Likely cause: Dense reactive perilesional sclerosis in cortical intracortical OO — common in long-standing lesions.
Next step: Switch to diamond-tip drill bit attachment on coaxial system. Apply firm steady pressure with rotational motion — avoid excessive torque that can deviate trajectory. Consider manual bone drill as backup. If biopsy is indicated, perform concurrent drill biopsy of nidus material. Confirm trajectory on CT before fully advancing.
Problem
Cannot identify or confirm nidus on CT
Likely cause: Nidus very small (<5 mm), heavily calcified, or reactive sclerosis is overwhelming. Suboptimal CT technique (thick slices).
Next step: Correlate with bone scan — site of maximum uptake corresponds to nidus. Consider nuclear medicine probe (gamma probe) guidance in the procedure suite. Request MRI-guided ablation if available (LITT). If still uncertain after correlation, target the area of maximum bone scan activity within the sclerotic zone.
Problem
Probe tip near articular cartilage
Likely cause: Intra-articular or periarticular OO at hip, knee, or ankle — relatively common; up to 13% of OO are intra-articular.
Next step: Reduce power setting and shorten ablation cycle duration to minimize thermal spread. Inject saline or D5W into the joint to create a heat-sink buffer. If ≤1 cm from cartilage, strongly consider cryoablation — iceball is visible on CT and cryo preserves cartilage better than heat-based modalities.
Problem
Spinal lesion near nerve root or spinal canal
Likely cause: Posterior element OO (pedicle, lamina, facet) — proximity to epidural space or neural foramen is the critical risk.
Next step: Place temperature monitoring probe adjacent to neural structures; abort if >45°C reached. Perform D5W epidural cooling via separately placed epidural needle (D5W does not stimulate neural tissue at low temperatures). CO2 pneumodissection can physically separate the nidus from the neural structures. Consider cryoablation — cryo is better characterized near neural structures and the iceball is visible.
Problem
Hemodynamic response during ablation (hypertension / tachycardia)
Likely cause: Expected — osteoid osteomas contain prostaglandins at 100–1,000× normal levels; ablation releases these, causing transient cardiovascular stimulation.
Next step: Warn anesthesia team before ablation begins. This is a recognized phenomenon — manage with short-acting antihypertensives or beta-blockers as needed. Symptoms resolve when ablation is turned off. Document and reassure.
7
Complications
Periprocedural / Early
- Post-procedure pain flare (expected, not a complication per se) — typically 1–3 days of increased pain; managed with NSAIDs + short course of acetaminophen; warn patient before discharge
- Skin burn — risk with subperiosteal lesions; prevent with hydrodissection (saline or D5W) between nidus and skin; treat with standard wound care
- Intraosseous bleeding / hematoma — usually self-limited; hemostatic plug at access tract reduces risk
- Hemodynamic instability (transient hypertension/tachycardia) — prostaglandin-mediated; resolves with ablation cessation; coordinate with anesthesia
Delayed / Major
- Incomplete ablation / Recurrence (~5–10%) — persistent or recurrent symptoms after initial apparent success; repeat RFA is usually successful; correlate with repeat CT and bone scan at 3–6 months
- Infection / Osteomyelitis — rare (<1%); cefazolin prophylaxis is standard; fever + worsening pain post-procedure → MRI + ID consultation
- Pathologic fracture — risk if >50% cortical involvement; restrict weight-bearing 4–6 weeks for high-risk lesions; prophylactic fixation rarely required
- Neurologic injury — <1% with appropriate thermal protection for spinal lesions; presents as new radiculopathy or weakness; MRI workup; usually resolves with conservative management
- Growth plate injury — pediatric patients; avoid ablation zone crossing open physis; confirm safe distance on pre-procedure CT
8
Critical Pearls
✶
Confirm the nidus — reactive sclerosis is not the target. The dense sclerotic halo is conspicuous on CT and easy to mistake for the lesion. The true nidus is the central lucency within the sclerosis. Always identify and center the probe tip in the lucent zone, not the dense bone. Correlate with bone scan if the lucency is unclear.
✶
General anesthesia is strongly preferred. Periosteal drilling is one of the most painful procedures in IR. Inadequate anesthesia leads to patient movement during probe placement, which displaces the probe from the nidus and causes incomplete ablation or injury. Conscious sedation is an option in cooperative adults but GA is the standard — particularly for pediatric patients.
✶
Match the active tip to the nidus size. Use a 1-cm active tip for nidus ≤1 cm. Use a 2-cm tip or two overlapping 1-cm burns for nidus >1 cm. Undersizing the ablation zone is the leading cause of incomplete ablation and recurrence. Measure the nidus diameter on pre-procedure CT.
✶
Spinal osteoid osteoma requires posterior entry and neural protection. Posterior element lesions (pedicle, lamina, facet) are accessed via a posterior approach. Confirm probe tip ≥1 cm from the spinal canal on axial CT before ablation. Use CO2 pneumodissection or D5W epidural cooling to protect nerve roots. Temperature monitoring is mandatory at these sites.
✶
Pediatric-specific considerations. Use shortest possible anesthesia duration. Confirm probe trajectory does not cross the open physis — document growth plate clearance on pre-procedure CT. Use weight-based cefazolin dosing. Overnight observation is appropriate at many pediatric institutions. These patients have excellent outcomes and near-immediate symptom relief when successful.
✶
Outcomes: technical success >95%, symptom relief >90% at 1 year. Rosenthal et al. established the foundational data for percutaneous RFA in osteoid osteoma (Radiology, 1998), with subsequent series confirming durable results. Recurrence (~5–10%) is managed successfully with repeat ablation in most cases. Image-guided ablation has replaced surgical resection as the primary treatment modality.
9
References
Citations
- Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology: A Case-Based Approach. Thieme; 2024. Chapters 37–38 (Macha V, Devane AM, Gunn AJ). DOI: 10.1055/b000000387
- Rosenthal DI, Hornicek FJ, Wolfe MW, Jennings LC, Gebhardt MC, Mankin HJ. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998;80(6):815–821.
- Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–175.
- Kransdorf MJ, Stull MA, Gilkey FW, Moser RP Jr. Osteoid osteoma. Radiographics. 1991;11(4):671–696.
- Chai JW, Hong SH, Choi JY, et al. Radiologic diagnosis of osteoid osteoma: from simple to challenging findings. Radiographics. 2010;30(3):737–749.
- Lindner NJ, Ozaki T, Roedl R, Gosheger G, Winkelmann W, Wörtler K. Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br. 2001;83(3):391–396.
- Coupal TM, Mallinson PI, Munk PL, et al. CT-guided percutaneous cryoablation for osteoid osteoma: initial experience in adults. AJR Am J Roentgenol. 2014;202(5):1136–1139.
- Vanderschueren GM, Taminiau AH, Obermann WR, Bloem JL. Osteoid osteoma: clinical results with thermocoagulation. Radiology. 2002;224(1):82–86.
9
References & Resources
Primary sources · Key data · Related procedures
Key Guidelines
- SIR Standards of Practice for Thermal Ablation
- CIRSE Standards of Practice for Bone Lesion Ablation
Primary References
- Rosenthal DI et al. Osteoid osteoma: percutaneous radio-frequency ablation. Radiology. 1998;209(3):794-798.
- Gangi A et al. Percutaneous laser photocoagulation of spinal osteoid osteomas under CT guidance. AJNR Am J Neuroradiol. 1998;19(10):1955-1958.
- Vanderschueren GM et al. The natural history of osteoid osteoma. J Bone Joint Surg Am. 2005;87(8):1795-1800.